Adverse events after COVID-19 vaccination in the pediatric population in Spain
Introduction: In December 2021, Spain launched its COVID-19 vaccination campaign for children aged 5–11 years. Although the Comirnaty® vaccine exhibited a favorable safety profile in premarketing trials, its rapid deployment and novel mRNA technology raised concerns among the public, leading to pare...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Espanhol |
| Gepubliceerd in: |
Elsevier
2026-02-01
|
| Reeks: | Anales de Pediatría (English Edition) |
| Onderwerpen: | |
| Online toegang: | http://www.sciencedirect.com/science/article/pii/S2341287926000189 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|